Skip to main content
eScholarship
Open Access Publications from the University of California

UC San Diego

UC San Diego Previously Published Works bannerUC San Diego

Pharmacological reversal of synaptic and network pathology in human MECP2-KO neurons and cortical organoids.

  • Author(s): Trujillo, Cleber A;
  • Adams, Jason W;
  • Negraes, Priscilla D;
  • Carromeu, Cassiano;
  • Tejwani, Leon;
  • Acab, Allan;
  • Tsuda, Ben;
  • Thomas, Charles A;
  • Sodhi, Neha;
  • Fichter, Katherine M;
  • Romero, Sarah;
  • Zanella, Fabian;
  • Sejnowski, Terrence J;
  • Ulrich, Henning;
  • Muotri, Alysson R
  • et al.
Abstract

Duplication or deficiency of the X-linked MECP2 gene reliably produces profound neurodevelopmental impairment. MECP2 mutations are almost universally responsible for Rett syndrome (RTT), and particular mutations and cellular mosaicism of MECP2 may underlie the spectrum of RTT symptomatic severity. No clinically approved treatments for RTT are currently available, but human pluripotent stem cell technology offers a platform to identify neuropathology and test candidate therapeutics. Using a strategic series of increasingly complex human stem cell-derived technologies, including human neurons, MECP2-mosaic neurospheres to model RTT female brain mosaicism, and cortical organoids, we identified synaptic dysregulation downstream from knockout of MECP2 and screened select pharmacological compounds for their ability to treat this dysfunction. Two lead compounds, Nefiracetam and PHA 543613, specifically reversed MECP2-knockout cytologic neuropathology. The capacity of these compounds to reverse neuropathologic phenotypes and networks in human models supports clinical studies for neurodevelopmental disorders in which MeCP2 deficiency is the predominant etiology.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View